Wadsworth JDF, Hill AF, Beck JA, Collinge J. Molecular and clinical classification of human prion disease. Br Med Bull. 2003;66:241–54.
Article
CAS
PubMed
Google Scholar
Knight RSG, Will RG. Prion Diseases. J Neurol Neurosurg Psychiatry. 2004;75:i36–42. doi:10.1136/jnnp.2004.036137.
Article
PubMed
PubMed Central
Google Scholar
Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci. 2001;24:519–50. doi:10.1146/annurev.neuro.24.1.519.
Article
CAS
PubMed
Google Scholar
Budka H. Neuropathology of prion diseases. Br Med Bull. 2003;66:121–30.
Article
CAS
PubMed
Google Scholar
Perry A, Brat DJ. Practical surgical neuropathology: a diagnostic approach. London: Churchill Livingstone; 2010.
Google Scholar
Aguzzi A, Calella A. Prions: protein aggregation and infectious diseases. Physiol Rev. 2009;89:1105–52.
Article
CAS
PubMed
Google Scholar
Riesner D. Biochemistry and structure of PrP-C and PrP-Sc. Br Med Bull. 2003;66:21–33.
Article
CAS
PubMed
Google Scholar
Linden R, Martins VR, Prado MAM, et al. Physiology of the prion protein. Physiol Rev. 2008;88:673–728. doi:10.1152/physrev.00007.2007.
Article
CAS
PubMed
Google Scholar
Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136–44.
Article
CAS
PubMed
Google Scholar
Basler K, Oesch B, Scott M, et al. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell. 1986;46:417–28.
Article
CAS
PubMed
Google Scholar
Drisaldi B, Stewart RS, Adles C, et al. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J Biol Chem. 2003;278:21732–43. doi:10.1074/jbc.M213247200.
Article
CAS
PubMed
Google Scholar
Hetz C, Russelakis-Carneiro M, Maundrell K, et al. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J. 2003;22:5435–45. doi:10.1093/emboj/cdg537.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brown AR, Rebus S, McKimmie CS, et al. Gene expression profiling of the preclinical scrapie-infected hippocampus. Biochem Biophys Res Commun. 2005;334:86–95. doi:10.1016/j.bbrc.2005.06.060.
Article
CAS
PubMed
Google Scholar
Hetz C, Russelakis-Carneiro M, Wälchli S, et al. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci. 2005;25:2793–802. doi:10.1523/JNEUROSCI.4090-04.2005.
Article
CAS
PubMed
Google Scholar
Dossena S, Imeri L, Mangieri M, et al. Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model. Neuron. 2008;60:598–609. doi:10.1016/j.neuron.2008.09.008.
Article
CAS
PubMed
Google Scholar
Tang Y, Xiang W, Terry L, et al. Transcriptional analysis implicates endoplasmic reticulum stress in bovine spongiform encephalopathy. PLoS One. 2010;5:e14207. doi:10.1371/journal.pone.0014207.
Article
CAS
PubMed
PubMed Central
Google Scholar
Torres M, Castillo K, Armisén R, et al. Prion protein misfolding affects calcium homeostasis and sensitizes cells to endoplasmic reticulum stress. PLoS One. 2010;5:e15658. doi:10.1371/journal.pone.0015658.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moreno JA, Radford H, Peretti D, et al. Sustained translational repression by eIF2α-P mediates prion neurodegeneration. Nature. 2012;485:507–11. doi:10.1038/nature11058.
CAS
PubMed
PubMed Central
Google Scholar
Rutkowski DT, Kaufman RJ. A trip to the ER: coping with stress. Trends Cell Biol. 2004;14:20–8. doi:10.1016/j.tcb.2003.11.001.
Article
CAS
PubMed
Google Scholar
Forman MS, Lee VM-Y, Trojanowski JQ. “Unfolding” pathways in neurodegenerative disease. Trends Neurosci. 2003;26:407–10. doi:10.1016/S0166-2236(03)00197-8.
Article
CAS
PubMed
Google Scholar
Schönthal AH. Endoplasmic reticulum stress: its role in disease and novel prospects for therapy. Scientifica (Cairo). 2012;2012:857516. doi:10.6064/2012/857516.
Google Scholar
Roussel BD, Kruppa AJ, Miranda E, et al. Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol. 2013;12:105–18. doi:10.1016/S1474-4422(12)70238-7.
Article
CAS
PubMed
Google Scholar
Scheper W, Hoozemans JJM. The unfolded protein response in neurodegenerative diseases: a neuropathological perspective. Acta Neuropathol. 2015. doi:10.1007/s00401-015-1462-8.
PubMed
PubMed Central
Google Scholar
Nijholt DAT, van Haastert ES, Rozemuller AJM, et al. The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies. J Pathol. 2012;226:693–702. doi:10.1002/path.3969.
Article
CAS
PubMed
Google Scholar
Hoozemans JJM, van Haastert ES, Nijholt DAT, et al. The unfolded protein response is activated in pretangle neurons in Alzheimer’s disease hippocampus. Am J Pathol. 2009;174:1241–51. doi:10.2353/ajpath.2009.080814.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stutzbach LD, Xie SX, Naj AC, et al. The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer’s disease. Acta Neuropathol Commun. 2013;1:31. doi:10.1186/2051-5960-1-31.
Article
PubMed
PubMed Central
Google Scholar
Köhler C. Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology. Acta Neuropathol. 2016. doi:10.1007/s00401-016-1562-0.
PubMed
Google Scholar
Unterberger U, Höftberger R, Gelpi E, et al. Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J Neuropathol Exp Neurol. 2006;65:348–57. doi:10.1097/01.jnen.0000218445.30535.6f.
Article
CAS
PubMed
Google Scholar
Jansen C, Parchi P, Capellari S, et al. Human prion diseases in the Netherlands (1998–2009): Clinical, genetic and molecular aspects. PLoS One. 2012. doi:10.1371/journal.pone.0036333.
Google Scholar
Parchi P, Capellari S, Chen SG, et al. Typing prion isoforms. Nature. 1997;386:232–3. doi:10.1037/e579292009-004.
Article
CAS
PubMed
Google Scholar
Parchi P, Zou W, Wang W, et al. Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A. 2000;97:10168–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Parchi P, Strammiello R, Notari S, et al. Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol. 2009;118:659–71. doi:10.1007/s00401-009-0585-1.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zaborowski A, Kordek R, Botts GT, Liberski PP. Immunohistochemical investigations of the prion protein accumulation in human spongiform encephalopathies. Special report II. Pol J Pathol. 2003;54:39–47.
CAS
PubMed
Google Scholar
Zou WQ, Gambetti P. Prions and diseases: volume 2, animals, humans and the environment. 2013. Springer Science + Business Media New York.
Book
Google Scholar
Cvetkovic-Dozic D, Skender-Gazibara M, Dozic S. Neuropathological hallmarks of Alzheimer’s disease. Arch Oncol. 2001;9:195–9.
Google Scholar
Verwey NA, Hoozemans JJM, Korth C, et al. Immunohistochemical characterization of novel monoclonal antibodies against the N-terminus of amyloid β-peptide. Amyloid. 2013;20:179–87. doi:10.3109/13506129.2013.797389.
Article
CAS
PubMed
Google Scholar
Reiniger L, Lukic A, Linehan J, et al. Tau, prions and Aβ: the triad of neurodegeneration. Acta Neuropathol. 2011;121:5–20. doi:10.1007/s00401-010-0691-0.
Article
CAS
PubMed
Google Scholar
Thal DR, Del Tredici K, Ludolph AC, et al. Stages of granulovacuolar degeneration: Their relation to Alzheimer’s disease and chronic stress response. Acta Neuropathol. 2011;122:577–89. doi:10.1007/s00401-011-0871-6.
Article
CAS
PubMed
Google Scholar
Jansen C, Parchi P, Capellari S, et al. Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. Acta Neuropathol. 2010;119:189–97. doi:10.1007/s00401-009-0609-x.
Article
CAS
PubMed
Google Scholar
Hoozemans JJ, Veerhuis R, van Haastert ES, et al. The unfolded protein response is activated in Alzheimer’s disease. Acta Neuropathol. 2005;110:165–72. doi:10.1007/s00401-005-1038-0.
Article
CAS
PubMed
Google Scholar
Hoozemans JJM, van Haastert ES, Eikelenboom P, et al. Activation of the unfolded protein response in Parkinson’s disease. Biochem Biophys Res Commun. 2007;354:707–11. doi:10.1016/j.bbrc.2007.01.043.
Article
CAS
PubMed
Google Scholar
Murray FE, Landsberg JP, Williams RJ, et al. Elemental analysis of neurofibrillary tangles in Alzheimer’s disease using proton-induced X-ray analysis. Ciba Found Symp. 1992;169:201–10.
CAS
PubMed
Google Scholar
Stamer K, Vogel R, Thies E, et al. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol. 2002;156:1051–63. doi:10.1083/jcb.200108057.
Article
CAS
PubMed
PubMed Central
Google Scholar
Verkhratsky A. Physiology and Pathophysiology of the Calcium Store in the Endoplasmic Reticulum of Neurons. Physiol Rev. 2005;85:201–79.
Article
CAS
PubMed
Google Scholar
Fu Z, Yang Y, Song J, et al. LiCl Attenuates Thapsigargin-Induced Tau Hyperphosphorylation by Inhibiting GSK-3 β In Vivo and In Vitro. 2010;21:1107–17. doi:10.3233/JAD-2010-100687.
Ho Y-S, Yang X, Lau JC-F, et al. Endoplasmic reticulum stress induces tau pathology and forms a vicious cycle: implication in Alzheimer’s disease pathogenesis. J Alzheimers Dis. 2012;28:839–54. doi:10.3233/JAD-2011-111037.
CAS
PubMed
Google Scholar
Nijholt DAT, Nölle A, van Haastert ES, et al. Unfolded protein response activates glycogen synthase kinase-3 via selective lysosomal degradation. Neurobiol Aging. 2013;34:1759–71. doi:10.1016/j.neurobiolaging.2013.01.008.
Article
CAS
PubMed
Google Scholar
Lin L, Yang S-S, Chu J, et al. Region-specific expression of tau, amyloid-β protein precursor, and synaptic proteins at physiological condition or under endoplasmic reticulum stress in rats. J Alzheimers Dis. 2014;41:1149–63.
CAS
PubMed
Google Scholar
van der Harg JM, Nölle A, Zwart R, et al. The unfolded protein response mediates reversible tau phosphorylation induced by metabolic stress. Cell Death Dis. 2014;5:e1393. doi:10.1038/cddis.2014.354.
Article
PubMed
PubMed Central
Google Scholar
Radford H, Moreno JA, Verity N, et al. PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia. Acta Neuropathol. 2015;130:633–42. doi:10.1007/s00401-015-1487-z.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ghetti B, Piccardo P, Spillantini MG, et al. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci U S A. 1996;93:744–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jayadev S, Nochlin D, Poorkaj P, et al. Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype. Ann Neurol. 2011;69:712–20. doi:10.1002/ana.22264.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ishizawa K, Komori T, Shimazu T, et al. Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann-Sträussler-Scheinker syndrome P102L mutation complicated with dementia. Acta Neuropathol. 2002;104:342–50. doi:10.1007/s00401-002-0547-3.
PubMed
Google Scholar
Revesz T, Holton JL. Anatamopathological spectrum of tauopathies. Mov Disord. 2003;18 Suppl 6:S13–20. doi:10.1002/mds.10558.
Article
PubMed
Google Scholar
Ghetti B, Tagliavini F, Giaccone G, et al. Familial Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Mol Neurobiol. 1994;8:41–8. doi:10.1007/BF02778006.
Article
CAS
PubMed
Google Scholar
Quaglio E, Restelli E, Garofoli A, et al. Expression of mutant or cytosolic PrP in transgenic mice and cells is not associated with endoplasmic reticulum stress or proteasome dysfunction. PLoS One. 2011;6:e19339. doi:10.1371/journal.pone.0019339.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moreno JA, Halliday M, Molloy C, et al. Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci Transl Med. 2013;5:206ra138. doi:10.1126/scitranslmed.3006767.
Article
PubMed
Google Scholar
Halliday M, Radford H, Sekine Y, et al. Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity. Cell Death Dis. 2015;6:e1672. doi:10.1038/cddis.2015.49.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jansen C, Voet W, Head MW, et al. A novel seven-octapeptide repeat insertion in the prion protein gene (PRNP) in a Dutch pedigree with Gerstmann-Sträussler-Scheinker disease phenotype: comparison with similar cases from the literature. Acta Neuropathol. 2011;121:59–68. doi:10.1007/s00401-010-0656-3.
Article
CAS
PubMed
Google Scholar
Jansen C, van Swieten JC, Capellari S, et al. Inherited Creutzfeldt-Jakob disease in a Dutch patient with a novel five octapeptide repeat insertion and unusual cerebellar morphology. J Neurol Neurosurg Psychiatry. 2009;80:1386–9. doi:10.1136/jnnp.2008.169359.
Article
CAS
PubMed
Google Scholar
Jansen C, Parchi P, Capellari S, et al. A second case of Gerstmann-Sträussler-Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient. J Neuropathol Exp Neurol. 2011;70:698–702. doi:10.1097/NEN.0b013e3182270c54.
Article
PubMed
Google Scholar
Jansen C, Parchi P, Jelles B, et al. The first case of fatal familial insomnia (FFI) in the Netherlands: a patient from Egyptian descent with concurrent four repeat tau deposits. Neuropathol Appl Neurobiol. 2011;37:549–53. doi:10.1111/j.1365-2990.2010.01126.x.
Article
CAS
PubMed
Google Scholar
Sánchez-Juan P, Houben MPWA, Hoff JI, et al. The first case of variant Creutzfeldt-Jakob disease in The Netherlands. J Neurol. 2007;254:958–60. doi:10.1007/s00415-006-0360-3.
Article
PubMed
PubMed Central
Google Scholar
Jansen C, Head MW, Rozemuller AJM, Ironside JW. Panencephalopathic Creutzfeldt-Jakob disease in the Netherlands and the UK: clinical and pathological characteristics of nine patients. Neuropathol Appl Neurobiol. 2009;35:272–82. doi:10.1111/j.1365-2990.2008.01004a.x.
Article
CAS
PubMed
Google Scholar
Jansen C, Head MW, Van Gool WA, et al. The first case of protease-sensitive prionopathy (PSPr) in The Netherlands: a patient with an unusual GSS-like clinical phenotype. J Neurol Neurosurg Psychiatry. 2010;81:1052–5. doi:10.1136/jnnp.2009.175646.
Article
CAS
PubMed
Google Scholar